The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

Kura Oncology and Kyowa Kirin have shared details of the phase 2 win for their oral leukemia treatment ziftomenib as the FDA ...

An international clinical trial co-led by Roswell Park Comprehensive Cancer Center has demonstrated that the investigational ...

The Houston Texans are no exception. Bleacher Report's Moe Moton published an article Saturday suggesting one move every team ...

The Houston Texans added a lot of new faces to their receiving corps this offseason. They acquired Christian Kirk from ...

Using the National Cancer Database, this retrospective cohort study identified 23,397 ALL patients between the ages of 0-18 who received chemotherapy from 2004-2020. Patients with race listed as ...

This article aims to review the current application status and research advancements of selinexor in the treatment of acute myeloid leukemia (AML). Selinexor, as the first oral selective inhibitor of ...

The introduction of ATRA had prompted several study groups to explore the role of ATRA either as a single agent or in combination with chemotherapy. Although treatment with single-agent ATRA ...

Aside from the advances seen in the treatment of acute promyelocytic leukemia (APL), which occurred in parallel with, but not dependent on, the molecular biology, the large majority of these ...

Except when given into the CSF, these drugs enter the bloodstream and reach all areas of the body, making this treatment useful for cancers such as leukemia that spread throughout the body. Phases of ...

People with a certain type of AML called acute promyelocytic leukemia (APL) might have problems with bleeding and blood clotting. They might have a nosebleed that won’t stop, or a cut that won’t stop ...